 Scrip Asia Pacific The US Food and Drug Administration wants to reduce the regulatory burden on low-risk technologies, according to Henry Roberts, digital health specialist at the agency’s Office of Strategic Partnershi 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
